Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 EUR | -.--% |
|
+0.79% | -18.59% |
04-23 | Maps, to group company project from Novara Health Authority | AN |
03-28 | Futures tentatively up, eyes on macros | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.59% | 33.71M | - | ||
-13.54% | 190B | A- | ||
+2.92% | 169B | B+ | ||
+5.75% | 159B | B- | ||
+2.46% | 97.69B | A- | ||
+50.08% | 93.25B | C- | ||
+17.01% | 85.67B | A- | ||
+1.55% | 77.83B | A | ||
-0.44% | 47.42B | A- | ||
-32.12% | 45.23B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MAPS Stock
- Ratings Maps S.p.A.